Polyvalent recombinant Marek's disease virus vaccine against poultry diseases

Current Topics in Microbiology and Immunology

Volumn 255, Issue , 2000, Pages 261-287

  Hirai, K ^a   Sakaguchi, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; HYBRID PROTEIN; MATERNAL ANTIBODY; RECOMBINANT VACCINE; VIRUS DNA; VIRUS VACCINE; VIRUS VECTOR;

AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; FOWLPOX VIRUS; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; REOVIRUS; RETROVIRUS; REVIEW; SITE DIRECTED MUTAGENESIS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; BIRDS; FOWLPOX VIRUS; GENETIC VECTORS; GENOME, VIRAL; HERPESVIRUS 2, GALLID; MAREK DISEASE; MAREK DISEASE VACCINES; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY; POULTRY DISEASES; RECOMBINATION, GENETIC; VACCINATION; VACCINES, SYNTHETIC;

ANIMALIA; AVES; DNA VIRUSES; FOWLPOX VIRUS; GALLID HERPESVIRUS 2; HERPETOVIRUS; MARDIVIRUS; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; REOVIRUS SP.; UNIDENTIFIED RETROVIRUS;

EID: 0034533532     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (123)

1. Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations
2. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus
3. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox virus
4. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus
5. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus
6. Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants
7. Recombinant fowlpox virus vaccines for poultry
8. The Marek's disease virus (MDV) unique short region: Alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes
9. Retrotransposition and herpesvirus evolution
10. Nonessential loci in the BamHI-I and -F fragments of the HVT FC126 genome
11. Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticutoendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens
12. Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene
13. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture
14. Retroviridae: The viruses and their replication
15. Vaccination of broilers with HVT expressing an Eimeria Acervulina antigen improves performance after challenge with Eimeria
16. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens
17. Multiple infection of chickens and turkeys with avian oncogenic viruses; Prevalence and molecular analysis
18. Mutagenesis and characterization of a 41-kilobase-pair region of the pseudorabies virus genome: Transcription map, search for virulence genes, and comparison with homologs of herpes simplex virus type 1
19. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene
20. Retroviral sequence located in border region of short unique region and short terminal repeat of Md5 strain of Marek's disease virus type I
21. A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens
22. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in micc
23. Interactions between Marek's disease herpesvirus and avian leucosis virus in tissue culture
24. Structure of Marek's disease virus DNA: Detailed restriction enzyme map
25. The structure of Marek disease virus DNA: The presence of unique expansion in nonpathogenic viral DNA
26. Sedimentation characteristics and molecular weights of three poxvirus DNAs
27. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents
28. Effect of breeder vaccination on immunization of progeny against Newcastle disease
29. The structure of Marek's disease virus DNA: Amplification of repeat sequence in IRs and TRs
30. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens
31. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens
32. Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus
33. Restriction endonuclease analysis of the genomes of virulent and avirulent Marek's disease viruses
34. Genetic relatedness of virulent and avirulent strains of Marek's disease virus
35. Evaluation of DNA homology of Marek's disease virus, herpesvirus of turkeys and Epstein-Barr virus under varied stringent hybridization conditions
36. Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus
37. Replicating Marek's disease virus (MDV) scrotype 2 DNA with inserted MDV serotype 1 DNA sequences in a Marek's disease lymphoblastoid cell line MSBI-41C
38. Construction of recombinant Marek's disease virus type I expressing the lacZ gene of Eschericia coli
39. Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells
40. Restriction enzyme map of herpesvirus of turkey DNA and its collinear relationship with Marek's disease virus DNA
41. Immunoprecipitation of Marek's disease virus-specific polypeptides with chicken antibodies purified by affinity chromatography
42. Most virus-specific polypeptides in cells productively infected with Marek's disease virus or herpesvirus of turkeys possess cross-reactive determinants
43. Processing of glycoprotein gB related to neutralization of Marek's disease virus and herpesvirus of turkeys
44. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV
45. Retrovirus insertion into herpesvims in vitro and in vivo
46. Retrovirus insertion into herpesviruses
47. Current and future recombinant viral vaccines for poultry
48. Increased susceptibility of leukemia-infected chickens to Marek's disease
49. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors
50. Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences
51. Retroviral insertional activation in a herpesvirus: Transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone
52. Copy number of tandem direct repeats within the inverted repeats of Marek's disease virus DNA
53. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity
54. Inverted repeat regions of Marek's disease virus DNA possess a structure similar to that of the a sequence of herpes simplex virus DNA and contain host cell telomere sequences
55. Retrovirus insertion into herpesvirus: Characterization of a Marek's disease virus harboring a solo LTR
56. Transforming potential of the herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis
57. Clustering of genes dispensable for growth in culture in the S component of the HSV-I genome
58. Vaccinia virus: A selectable eukaryotic cloning and expression vector
59. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage
60. Selection of Marek's disease virus recombinants expressing the Escherichia coli gpt gene
61. Pathogenicity and immunosuppressive properties of infectious bursal disease "intermediate" strains
62. The safe and effective use of fowlpox virus as a vector for poultry vaccines
63. Immunological studies of the functions of paramyxovirus glycoproteins
64. Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle disease
65. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein
66. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: Onset of protection and effect of maternal antibodies
67. Characterization of Marek's disease virus RB1B-based mutants having disrupted glycoprotein C or glycoprotein D homolog genes
68. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus
69. Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter
70. Protection against Newcastle disease by recombinant Marek's disease virus serotype 1 expressing the fusion protein of Newcastle disease virus
71. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus
72. A recombinant fowlpox virus expressing the envelope antigen of subgroup A avian leukosis/sarcoma virus
73. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus
74. Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses
75. Partial protection against Marek's disease in chickens immunized with glycoproteins gB purified from turkey-herpesvirus-infected cells by affinity chromatography coupled with monoclonal antibodies
76. The restriction endonuclease map of Marek's disease virus (MDV) serotype 2 and collinear relationship among three serotypes of MDV
77. Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus
78. Characterization of Marek's disease virus insertion and deletion mutants that lack USI (ICP22 homolog), USI0, and/or US2 and neighboring short-component open reading frames
79. Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene
80. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes
81. Studies of fowlpox virus recombination in the generation of recombinant vaccines
82. Biological and biochemical evidence for an interaction between Marek's disease herpesvirus and avian leukosis virus in vivo
83. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marck's diseases in specific-pathogen-free chickens
84. In ovo vaccination technology
85. Herpes simplex viruses and their replication
86. Restriction endonuclease analysis of Marek's disease virus DNA and homology between strains
87. Properties and evolutionary relationships of the Marek's disease virus homologues of protein kinase, glycoprotein D and glycoprotein I of herpes simplex virus
88. Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus
89. Sequence determination and genetic content of an 8.9-kb restriction fragment in the short unique region and the internal inverted repeat of Marek's disease vires type 1 DNA
90. Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens
91. Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: The US10 gene of MDVI as a stable insertion site
92. Marek's disease virus type 1 as a vaccine vector for poultry diseases
93. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus
94. Insertion of tandem direct repeats consisting of avian leukosis virus LTR sequences into the inverted repeat region of Marek's disease virus type 1 DNA
95. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1
96. Open reading frame LI of Marek's disease herpesvirus is not essential for in vitro and in vivo virus replication and establishment of latency
97. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus
98. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination
99. Role of maternal antibodies in immunization of chicks against Newcastle disease virus
100. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease
101. Viral vectors for veterinary vaccines
102. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage
103. Avian herpesvirus as a live Viral vector for the expression of heterologous antigens
104. Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease
105. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 (MDVI) in commercial chickens with maternal antibodies
106. Fowlpox virus us a vector in non-avian species
107. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens
108. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge
109. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion
110. Expression of avian influenza virus hemugglutinin by recombinant fowlpox virus
111. Efficacy of three live vaccines against highly virulent infectious bursal disease virus in chickens with or without maternal antibodies
112. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2
113. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization
114. Expression of a novel Marek's disease virus type I (MDVI)-specific protein p40 in insect cells by a baculovirus vector and in chick embryo fibroblasts infected with MDV1
115. Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells
116. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis
117. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens
118. Principles of vaccination
119. Attenuated revertant serotype 1 Marek's disease viruses: Safety and protective efficacy
120. Recent developments in the prevention and control of Marek's disease
121. The complete sequence and gene organization of the short unique region of herpesvirus of turkeys